Predictive variables of sustained virological response after early discontinuation of triple therapy with telaprevir for genotype-1 HCV infection

Acero Fernández, Doroteo; Morillas Cunill, Rosa; Ferri Iglesias, María José; Torras Collell, Xavier; Vergara Gómez, Mercedes; Zaragoza Velasco, Natividad; López Nuñez, Carmen; Forné Bardera, Montserrat; Delgado Gómez, Mercedes; Barenys Lacha, Mercè; Torres Salinas, Miquel; Villar Fernández, Margarita; Durández Lázaro, Rosa; Mariño Mendez, Zoe.
Gastroenterol. hepatol. (Ed. impr.) ; 39(6): 377-384, jun.-jul. 2016. tab
Artículo en Inglés | IBECS (España) | ID: ibc-154792

Documentos relacionados

  1. Predictive variables of sustained virological response after early discontinuation of triple therapy with telaprevir for genotype-1 HCV infection.
  2. Período de lead-in y semana 8 como herramientas de predicción de la respuesta en el tratamiento con boceprevir: estudio retrospectivo de la práctica clínica real en España
  3. Enhancing our understanding of current therapies for hepatitis C virus (HCV).
  4. Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR.
  5. The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and Persistence.
  6. Gene therapies for hepatitis C virus.
  7. Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir.
  8. Notification and counselling of hepatitis positive blood donors, their immediate emotional response, contact-testing and their follow-up: Study from a tertiary care hospital!
  9. Impact of Substance Use Disorder on the Rate of Sustained Virological Response in Veterans With Chronic Hepatitis C Treated With Direct-Acting Antivirals.
  10. Evaluation of Temporal Virological Responses to Interferon-α-2b plus Ribavirin among Genotype 3a Hepatitis C Virus-Infected Patients.